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Abstract.Correct and rapid identification of microorganisms is the key to the success
of many important applications in health and safety, including, but not limited to,
infection treatment, food safety, and biodefense. With the advance of mass spec-
trometry (MS) technology, the speed of identification can be greatly improved.
However, the increasing number of microbes sequenced is challenging correct
microbial identification because of the large number of choices present. To properly
disentangle candidate microbes, one needs to go beyond apparent morphology or
simple ‘fingerprinting’; to correctly prioritize the candidate microbes, one needs to
have accurate statistical significance in microbial identification. We meet these
challenges by using peptidome profiles of microbes to better separate them and by
designing an analysis method that yields accurate statistical significance. Here, we present an analysis pipeline
that uses tandemMS (MS/MS) spectra for microbial identification or classification. We have demonstrated, using
MS/MS data of 81 samples, each composed of a single known microorganism, that the proposed pipeline can
correctly identifymicroorganisms at least at the genus and species levels.We have also shown that the proposed
pipeline computes accurate statistical significances, i.e., E-values for identified peptides and unified E-values for
identified microorganisms. The proposed analysis pipeline has been implemented in MiCId, a freely available
software for Microorganism Classification and Identification. MiCId is available for download at http://www.ncbi.
nlm.nih.gov/CBBresearch/Yu/downloads.html.
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Introduction
Correct and rapid identification of microorganisms is thekey to the success of many important applications in
health and safety, including, but not limited to, infection treat-
ment, food safety, and biodefense. State-of-the-art technologies
for microbial identification include both next generation se-
quencing and mass spectrometry (MS). The former method,
although being a newer technology and having great success,
generally needs extensive sample preparations and a consider-
able amount of data analysis time [1, 2]. On the other hand,
several studies have demonstrated the capability of MS-based
technology in identifying microorganisms with a high degree
of accuracy [3–6]. This technology is being employed to rap-
idly identify pathogens in clinical settings, to improve food
safety by detecting bacterial contaminants, to detect pathogens
relevant to biodefense, to assist in the identification of novel
microorganisms, and to classify microorganisms phylogeneti-
cally [7–12]. The idea of using MS-based technology to iden-
tify microorganisms dates back to 1970s [13–15]. However, it
was not until sufficient progress was made—in the fields of
MS, DNA sequencing and bioinformatics—that MS-based
Electronic supplementary material The online version of this article (doi:10.
1007/s13361-015-1271-2) contains supplementary material, which is available
to authorized users.
Correspondence to: Yi–Kuo Yu; e-mail: yyu@ncbi.nlm.nih.gov
6
methods became practical for identifying microorganisms [16–
22].
There are different methods that employ MS-based technol-
ogy to identify pathogens. Of these methods, matrix-assisted
laser desorption/ionization (MALDI)-based systems [23–25]
and polymerase chain reaction electrospray ionization mass
spectrometry (PCR-ESI-MS)-based systems have been the fo-
cus of most research in this direction [26–29]. Comparison
between these two systems in terms of their ability to accurately
identify microorganisms has been performed with no signifi-
cant difference found, both having about 95% identification
accuracy at the species level [4]. Evaluations of microbial
identification accuracy of different MALDI-based systems
have also reported comparable performance [5, 6]. In the next
two paragraphs, we briefly summarize the PCR-ESI-MS- and
MALDI-based systems; the listed citations therein provide
more detailed and comprehensive descriptions of both systems.
The PLEX-ID system produced by Abbot Molecular was
the main commercially available PCR-ESI-MS-based system;
it is also known as the T5000 system in earlier publications
[26–28]. Abbot discontinued the manufacturing of the PLEX-
ID system in 2012, although it continues to be used in many
research labs [30, 31]. Sample preparation for PCR-ESI-MS-
based systems requires extracting nucleic acids from clinical
specimens or from cultivated microbial isolates [29, 30, 32].
The extracted DNA is then transferred into a 96-well plate,
where each well usually contains a single set of broad-range
PCR primers for DNA amplification. After PCR amplification,
the sample is desalted and sent to a mass spectrometer where
the mass over charge (m/z) of the amplicons are measured [9].
Microbial identification is done using a commercial software
that makes microbial inferences based on the following as-
sumptions: genetic targets must be present for primers used, a
small number of possible base compositions must be associated
with a measured amplicon m/z, and observed amplicons m/z
values must have matches for the designed genetic primer
regions in a microbial DNA database. If all the above assump-
tions are satisfied, this is a robust technology. Some, however,
criticize the small number of amplicons measured and caution
the possibility of the formation of chimeric DNA, especially
when analyzing a sample made of more than one microorgan-
ism [11, 29, 33].
Two main commercially available MALDI-based systems
are the BioTyper (Bruker Daltonics, Bremen, Germany) and
the VITEX MS (BioMérieux, Marcy l′Etoile, France).
Advantages of these systems include simple operation, low
cost, and short time for sample analysis. For microbial identi-
fication, one needs a purified microbial culture, which is then
mixed with an absorbing organic acid (matrix); the mixture is
then allowed to air dry and it is finally placed in the MALDI-
TOFmass spectrometer [3, 23–25, 34]. Ionizing the mixture by
laser, theMALDI-TOF system produces the correspondingm/z
spectrum and queries it against a MALDI-TOF mass spectral
database [35] for identification (i.e., using the spectrum as a
fingerprint for the underlying microorganism). Even though
MALDI-based systems yield reproducible and accurate
microbial identifications [3, 23–25, 34, 36], there remain areas
that can be improved upon. For example, there is a need for
statistical significance assignment in fingerprint matching [37].
Also, even though sample preparation methods have been
standardized [38], the optimal protocol appears to vary by
microorganism [37]. Further, growth medium seems to affect
identification specificity [39]; significant mass fingerprint fluc-
tuations have been observed for filamentous fungi because of
changes in culture conditions [40]. Another challenging issue
for MALDI-based systems pertains to polymicrobial culture
attributable to complex infections or contaminants [9].
In this manuscript, we present an analysis pipeline for
microbial identification or taxonomic classification using tan-
dem MS (MS/MS) spectra as input. To facilitate reading, we
have provided an acronym list in Table 1. All proteomics data
used are produced by high resolution mass analyzers [41, 42],
yielding high mass accuracy for both precursor and product
ions. Mass accuracy of these instruments in daily operation can
range from 1 to 10 parts per million (ppm) depending on
several factors [42]. Higher mass accuracy is desirable because
more accurate assignment of charge and mass to precursor and
product ions can be achieved, thus leading to a better sensitivity
in peptide identification. Liquid chromatography MS (LCMS)
experiments [43] can be viewed as complementary or as or-
thogonal to the MALDI- and PCR-ESI-MS-based systems.
While MALDI-based systems provide a fingerprint of a micro-
organism’s ionized cells and PCR-ESI-MS-based systems sup-
ply the m/z of a limited number of selected regions of a
microorganism’s genome, the data obtained by LCMS exper-
iments produce hundreds to thousands of confidently identified
peptides (CIPs) of a microorganism’s peptidome. Containing a
rich array of information, the CIPs, after proper analyses, can
be used to identify/classify microbes directly or in conjunction
with other approaches.
Table 1. List of Commonly Used Acronyms
Acronym Definition




E[X] expected value of variable X
Ec the E-value that E[FP] ≤ 1
FP false positives
IF identification fraction
NIP number of identified peptides
NUP number of unique peptides
MWET molecular weight error tolerance
ns number of MS/MS spectra from a given sample
nmw number of qualified peptides in the database




ppm parts per million
PNNL Pacific Northwest National Laboratory
R rank
SN sample number
SSE statistically significant E-value
WPC weighted peptide count
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Although several studies have demonstrated the usefulness of
MS/MS data in the identification of microorganisms [44–47],
only a few proposed computational methods are specifically
designed to perform microbial identification using MS/MS data.
An existing method infers microbial identification [48, 49] based
on confident identifications of peptides specific to certain micro-
organisms. This approach, however, might not be pragmatic
because one needs to construct a set of unique and experimentally
detectable peptides for each microorganism, and this set must be
continuously checked for uniqueness as protein sequences from
new microorganisms become available. Also, the presence of
these unique peptides might be questioned whenmicroorganisms
are cultured in different media [39]. There also exists another
approach [50] that utilizes a set of CIPs from a LCMS experi-
ment. This approach uses a mixture model that was learned from
a training dataset to compute posterior probabilities. For each
MS/MS spectrum, the posterior probability of the best ranked
peptide being a true positive is computed. In this approach, a
microorganism having the highest number of matched CIPs is
considered to be the correct identification [50]. A later develop-
ment extended the scope to include microbial classification by
generating a binary matrix, where a value of 1 is assigned if a
peptide belongs to a microorganism and 0 otherwise [51].
The analysis pipeline developed in this manuscript exhibits
similarities to all the aforementioned methods [48–51], but it
also differs from them in several fundamental aspects. First, all
identified peptides are considered in our approach. This is
important because a peptide’s fragmentation series currently
used by database search tools’ scoring functions are learned
empirically and collectively for all peptides rather than theo-
retically computed for each peptide [52]. Therefore, there can
be cases when the score differences among the top ranking
peptides are small, and utilizing only the best ranked identified
peptide per MS/MS spectrummight not be the best approach to
take. Second, our approach is built on a MS/MS spectrum-
specific measure, namely, E-value, which is computed per MS/
MS spectrum for all identified peptides [53, 54]. Evidently,
using a measure such as E-value or P-value that takes into
account spectrum specificity is more robust against cross-
spectrum or cross-experiment variations than utilizing an
unnormalized measure [55]. For example, if an unnormalized
measure, such as score, is used, a peptide identified with score
3 from MS/MS spectrum A can, in principle, signify a better
identification than another peptide identified with score 3.5
fromMS/MS spectrum B. By using the E-value, one can avoid
such a problem: one can simply compare and combine identi-
fied peptides across MS/MS spectra and even across different
experiments. Third, statistical significance in the form of a
unified E-value (Eu) is computed and assigned to identified
microorganisms. An Eu is computed by combining the E-
values of a microorganism’s CIPs [56] (i.e., whose E-values
fall below the cutoff set by demanding the expected number of
false positive (FP) peptides included in the analysis be <1).
In summary, in this manuscript we present an analysis pipe-
line that uses MS/MS spectra for microbial identification and/or
classification. Interpretation of the results depends on the
presence/absence of the correct microorganism in the database.
If we are certain that the correct microorganism is present in the
database, we should interpret the results as microbial identifica-
tion. On the other hand, if we are sure that the correct microor-
ganism is absent from the database, we may interpret the results
as microbial classification. We have demonstrated, using MS/
MS data of 81 samples, each composed of a single known
microorganism, that the proposed pipeline can correctly identify
microorganisms at least at the genus and species levels.We have
also shown that the proposed pipeline computes accurate statis-
tical significances (i.e., E-values for identified peptides and Eu
for identified microorganisms). The proposed analysis pipeline
has been implemented in MiCId, a freely available software for
Microorganism Classification and Identification.
Materials and Methods
In-House Dataset
Bacterial culture preparation: batch one Fresh Escherichia
coli (ATCC 25922) and Pseudomonas aeruginosa (ATCC
27853) plates were used to inoculate a 2 mL tryptic broth for
overnight growth. From each saturated culture, seven 2mL vials
were inoculated with 20 μL (1:100 dilution) and put in shaker at
37°C. The rest of the overnight culture was used for the saturated
time point. Each culture growth was monitored by nephelometer
and recorded in Table 2. To have approximately the same
number of cells in each sample, four tubes were combined for
the low time point and two tubes for themedium time point. One
tube was used for the high time point. Serial additions of each
time point were added to two Eppendorf tubes and spun at 14 K
rpm for 2 min until all of the sample was in the Eppendorf tube
and the supernatants discarded. These pellets were washed with
1 mL 70% EtOH and then resuspended in 150 μL 70% formic
acid. After vortexing, 150 μL acetonitrile was added and sam-
ples were vortexed and respun. Supernatants of each pair of
tubes were combined to create eight samples (E. coli,
P. aeruginosa) × Low, Medium, High, Saturated) with 600 μL
each. Each sample was divided into four tubes and speed-
vacuumed to dry. Two sets of these tubes were then digested.
To each tube, 40 μL of 5 M Gnd HCL and 25 mM NH4HCO3
was added, and the tube was sonicated for 45 min with occa-
sional vortexing. Samples were reduced with DTT
(2 μL1 M in water, 37°C for 60 min), alkylated (10 μL
iodoacetamide 40 mg/mL in water, at room temperature for 60
min in the dark), and quenched with D TT (2 μL, 15 min). The
tubes were neutralized by the addition of 200 μL 25 mM
NH4HCO3 containing 1 μL trypsin (Promega). Samples were
digested using the CEMDiscovery microwave digester (15 min,
56°C). After digestion, samples were stored at –20°C until used.
Bacterial culture preparation: batches two and three In ad-
dition to samples of Escherichia coli (ATCC 25922) and
Pseudomonas aeruginosa (ATCC 27853), the second batch
also contains samples from Salmonella enterica subspecies
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serovar Typhimurium (SL1344). In terms of sample prepara-
tion, all three batches largely follow the same procedures
except for steps indicated by the underlined text in the previous
subsection. For batches two and three, the aforementioned
underlined steps should be replaced by BTubes were diluted
by the addition of 200 μL 50 mM NH4HCO3, then
ProteaseMAX surfactant (3 μL of a 1% solution in 100 μL
50 mM NH4HCO3, Promega) was added to 0.01% final con-
centration and mixed gently. Trypsin was then added (2 μL of
500 μg/mL in 50 mM HOAc).^ In addition to the number of
microorganisms used, there is another small difference between
batch two and batch three: samples from batch three were all of
the medium growth range.
Liquid Chromatography-Tandem Mass
Spectrometry (LC-MS/MS) Acquisition
LC/MS-MS was performed using an Eksigent nanoLC-Ultra
2D system (Dublin, CA, USA) coupled to an Orbitrap Elite
mass spectrometer (Thermo Scientific, San Jose, CA, USA).
Twenty percent of each peptide sample was first loaded onto a
Zorbax 300SB-C18 trap column (Agilent, Palo Alto, CA,
USA) at a flow rate of 6 μL/min for 10 min, and then separated
on a reversed-phase BetaBasic C18 PicoFrit analytical column
(0.075 × 250 mm, NewObjective,Woburn, MA, USA) using a
90-min linear gradient of 5%–35% acetonitrile in 0.1% formic
acid at a flow rate of 250 nL/min. Eluted peptides were sprayed
into the Orbitrap Elite equipped with a nano-spray ionization
source. Both survey (MS) and product (MS/MS) spectra were
acquired in the Orbitrap, and the FTMS resolution was set at
30,000 and 15,000, respectively. Each MS scan was followed
by six data-dependent CID MS/MS scans with dynamic exclu-
sion. Other mass spectrometry settings were as follows: spray
voltage, 1.5 kV; full MS mass range, m/z 300 to 2000;
normalized collision energy, 35%. Supplementary Table S1
lists all spectral data of this in-house dataset.
Pacific Northwest National Laboratory Bacterial
Dataset
A public available dataset composed of 53 LCMS experiments
for six strains of bacteria was downloaded from the Pacific
Northwest National Laboratory (PNNL) website at http://
omics.pnl.gov/. This large dataset contains multiple high
resolution MS/MS runs per strain. Supplementary Table S2
provides a summary of the dataset downloaded. This dataset
was used to gauge the feasibility of the proposed method in
performingmicrobial identification at genus, species, and strain
level. Experimental details and optimized sample preparations
used to generate this dataset can be found in previously de-
scribed studies [57, 58]. Here, we briefly mention some impor-
tant experimental steps that differ between the production of
the PNNL dataset and that of the in-house dataset. Bacterial
cultures used in the PNNL dataset were diluted toOD 600 = 0.1
and allowed for an overnight growth to reach OD 600 = 3.0.
Overnight bacterial cultures were back-diluted to OD 600 = 0.1
and grew in two different flasks at 26°C. The cultures were
allowed to grow until OD 600 reached 0.5, at which time one of
the flasks was moved to 37°C. Aliquots from both cultures
were taken at 0, 1, 2, 4, 8 h and were pooled together into a
single flask. For each microbial sample, a modified bead beat-
ing method was applied to break the cell walls. Traditional
bead beating methods (used to lyse prokaryotes) can produce
heated aerosols of the pathogens because of the high speed of
shaking. Therefore a vortexing step with beads in solution was
used instead and followed by chilling to precipitate aerosols.
Trypsin 1:50 (enzyme:protein) ratio was added and digestion
occurred at 37°C for 3 h, and the sample was then quickly
frozen to stop the digestion.
Table 2. Monitor Culture Growth
Batch one Samples
Time (h) Sample label Number vials ODa E. coli OD P. aeruginosa
0:00 0.03 0.03
2:00 Low 4 0.30 0.38
3:30 Medium 2 0.75 0.65
5:00 High 1 1.07
6:00 High 1 0.90
14:00 Saturated 1 1.34 1.50
Batch two Samples
Time (h) Sample label Number vials ODa E. coli OD P. aeruginosa OD S. enterica
0:00 0.03 0.03 0.03
2:10 Low 4 0.34 0.43 0.42
3:00 Medium 2 0.66 0.68
3:40 Medium 2 0.64
5:40 High 1 1.01
7:10 High 1 1.12 0.96
14:00 Saturated 1 1.34 1.50 1.34
Batch three Samples
time (h) Sample label Number vials ODa E. coli OD P. aeruginosa
3:00–4:00 Medium 4 0.6–0.7 0.6–0.7
a Optical density (OD) 0.39≈8×108 cells. Roughly linear for OD between 0 and 0.40
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Microbial Peptide Sequence Database Construction
A bacterial peptide sequence database was constructed by
downloading all bacterial protein sequence fasta files from
the National Center for Biotechnology Information (NCBI) at
ftp://ftp.ncbi.nlm.nih.gov/genomes/Bacteria on July 15, 2013.
A total of 7989010 protein sequences from 2544 strains of
bacteria were downloaded and used for database construction.
Proteins were in silico digested following the digestion rule for
trypsin (i.e., cleaving at the carboxyl terminal of arginine and
lysine), allowing up to five missed cleavage sites. In our
bacterial peptide sequence database, only nonredundant
tryptic peptides with molecular weights between 660 and
6000 Da were kept; for each peptide, the names of strains,
species, and genera that contain this peptide are also recorded.
Taxonomic information was extracted from the taxonomy
files at http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/
wwwtax.cgi?name=Archaea&lvl=100 and at http://www.
ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?id=2&lvl=
100 on July 15, 2013. In the taxonomic files downloaded, some
microorganisms were classified only at the genus level but not
at the species and the strain level. For these microorganisms,
their genera names were also used as their species and strain
names. The 2544 bacteria strains downloaded belong to 1461
species and to 706 genera. Panels a, b, and c of Figure 1
display, respectively, the number of protein sequences of each
strain, the number of strains belonging to a given spe-
cies, and the number of species associated with a given
genus.
As recommended by previous studies, we employed a de-
coy database to assess the accuracy of the computed statistical
significance [55, 59]. The decoy peptide database was obtained
by first reversing the protein sequences followed by the peptide
database construction method mentioned above. This database
was used for evaluating the accuracy of the spectrum-specific
E-values assigned to identified peptides and the accuracy of the
Eu’s assigned to identified microorganisms.
A microbial peptide sequence database could also be con-
structed using the microorganisms’ genomes. Gene finding
tools such as GLIMMER [60, 61] can identify possible genes,
which can then be translated into putative proteins [44]. This
approach was not pursued here because the microorganisms
used in this study have a significant number of proteins avail-
able, averaging 3140 protein sequences per strain. However,
this approach could be useful for incorporating into the





















































































Figure 1. Status of bacterial database used in this investigation. The curve in panel (a) shows the number of proteins used for each
strain included in the database. Panel (b) ((c)) displays the number of strains (species) that belongs to a given species (genus).
With 0.01 Da as the bin size, panel (d) displays the histogram for the number of peptides present in the database as a function of the
molecular weight. The vertical dash-line (at 6000 Da) in panel (d) indicates the upper bound of molecular weight of peptides included
in the current database
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database newly discovered microorganisms whose document-
ed database proteins are few but whose complete genomes are
available.
Software and Parameters Used
Although there exist several software packages that have fully
automated peptide identifications [54, 62, 63] and protein
identifications [64–66] usingMS/MS data, not many have fully
automated microbial identifications. MiCId, our pipeline, was
designed to fully automate the process, from microbial peptide
database construction to microbial identification. The peptide
identification component of MiCId is derived from RAId_DbS
[54]. The structure and construction of MiCId’s peptide data-
base were described in the previous subsection. In this subsec-
tion and the next, we provide the parameters used and detail on
how statistical significances are computed for identified
microorganisms.
The MS/MS spectra used were acquired from
iodoacetamide alkylated samples, which were further digested
by trypsin. In addition to these conditions, all spectra analyzed
had in common the following database search parameters: b
and y ions were used for scoring peptides and only peptides
with E-value less than 10 were kept. To assess the accuracy of
the spectrum-specific E-values computed for identified
peptides, we use spectra from sample number (SN) 1–8 to
query a decoy bacterial peptide database with the following
parameters: allowing up to five missed cleavage sites (MCS)
per peptide andmolecular weight error tolerance (MWET) of 1,
5, and 10 ppm for both precursor and product ions (see
Figure 2). For statistical accuracy assessment of Eu’s computed
for identified microorganisms, spectra from SN1–SN81 were
used to search a decoy bacterial peptide database with the
following parameters: allowing up to five MCS per peptide
andMWET of 10 ppm for both precursor and product ions (see
Figure 3). To investigate the digestion efficiency of trypsin
under protocols one and two, MS/MS spectra from SN1–
SN20 were used to search a bacterial peptide database with
the following search parameters: maximum of 2, 3, 4, and 5
MCS were allowed per peptide and MWET of 10 ppm for both
precursor and product ions (see Table 6). To evaluate the
performance of MiCId in microbial identifications, we used
spectra from SN1–SN81 to search a bacterial peptide database
with the following parameters: allowing up to 5 MCS per
peptide and MWET of 10 ppm for both precursor and product
ions (see Tables 3, 4, 5, 7, and 8).
The computational time required for running MiCId de-
pends on the computational resources employed. As an illus-
tration, the microbial peptide database (needed for this study)









































































































































































































































































Figure 2. Accuracy assessment of the spectrum-specific E-value. The agreement between the expected error per query and the
computed E-value is examined using the MS/MS spectra from sample numbers 1–4, panels (a)–(c), and from sample numbers 5–8,
panels (d)–(e). Themolecular weight (MW) range considered while searching the database is [MW - 3⋅δ⋅MW,MW+ 3⋅δ⋅MW]. In each
panel the dashed line, y=x, corresponds to the theoretical line and is used to provide a visual guide regarding how close/off the
computed E-value curves are from the theoretical line
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occupies 80 GB of disk space. However, it is important to note
that this database construction is a one-time event; the
constructed database can be used for all subsequent spectral



































































Figure 3. Accuracy assessment of the unified E-value (Eu). The accuracy of the computed Eus is evaluated by plotting the E[Eu]
versus rank. The E[Eu]s at a given rank were obtained by averaging over all the computed Eus from sample numbers 1–81 having the
same rank. The curvemade of red circles displayed in panels (a), (b), (c) are the curves of E[Eu]s formicrobial identification performed
at the genus, species, and strain level. In each panel, the y=x line, corresponding to the theoretical line, together with the two dashed
lines, y=3x and y=x/3, provide a visual guide regarding the accuracy of the computed E[Eu] curves
Table 3. Bacterial Identification at the Genus Level for the PNNL Dataseta
Escherichia coli K-12 sample number 29-39
Genus IF E[R] E[ln (Eu)] E[WPC] E[NIP] E[NUP] E[CI]
Escherichia 11/11 1.0 –6498.6 ± 349.0 597.7 1594 15 1
Halorhodospira 2/11 2.0 –14.4 ± 3.0 1.7 12 1 6
C. Puniceispirillum 1/11 2.0 –6.4 ± 0.0 1.0 3 1 38
Enterococcus 1/11 3.0 –4.4 ± 0.0 1.0 2 1 5
Lacinutrix 1/11 2.0 –3.9 ± 0.0 1.0 2 0 24
Mycobacterium tuberculosis H37Rv sample number 40-48
Genus IF E[R] E[ln (Eu)] E[WPC] E[NIP] E[NUP] E[CI]
Mycobacterium 9/9 1.0 –6784.8 ± 729.6 725.6 937 433 1
Ethanoligenens 1/9 2.0 –6.3 ± 0.0 1.0 1 1 65
Salmonella 3/9 2.3 –5.6 ± 0.3 1.0 1 1 15
Methanoplanus 1/9 2.0 –4.5 ± 0.0 1.0 1 0 316
Treponema 2/9 2.5 –2.9 ± 0.1 0.5 3 0 3
Salmonella typhimurium ATCC 14028 sample number 49-56
Genus IF E[R] E[ln (Eu)] E[WPC] E[NIP] E[NUP] E[CI]
Salmonella 8/8 1.0 –5596.0 ± 670.5 546.8 1050 204 1
Halorhodospira 1/8 2.0 –14.4 ± 0.0 2.0 6 1 10
Planctomyces 1/8 2.0 –6.7 ± 0.0 1.0 2 1 14
Mycoplasma 1/8 3.0 –2.1 ± 0.0 1.0 5 0 2
Gordonia 3/8 5.3 –0.8 ± 2.4 0.7 3 0 7
Yersinia pestis CO92 sample number 57-65
Genus IF E[R] E[ln (Eu)] E[WPC] E[NIP] E[NUP] E[CI]
Yersinia 9/9 1.0 -9201.2 ± 897.8 847.0 1336 466 1
Azospirillum 1/9 2.0 –6.8 ± 0.0 1.2 6 0 2
C. Carsonella 1/9 2.0 –5.1 ± 0.0 1.0 1 1 9
Tannerella 1/9 3.0 –4.1 ± 0.0 1.0 3 0 16
Novosphingobium 1/9 3.0 –4.1 ± 0.0 1.2 7 0 10
Yersinia pseudotuberculosis PB1 Plus sample number 66-74
Genus IF E[R] E[ln (Eu)] E[WPC] E[NIP] E[NUP] E[CI]
Yersinia 9/9 1.0 –8043.2 ± 803.2 749.7 1187 400 1
Novosphingobium 1/9 2.0 –21.3 ± 0.0 3.0 9 2 7
Syntrophus 4/9 3.5 –1.5 ± 4.3 0.9 5 0 11
C. Uzinura 4/9 2.8 0.1 ± 0.8 0.2 2 0 63
Arcobacter 2/9 4.5 0.4 ± 0.4 0.5 4 0 5
Shewanella oneidensis MR-1 sample number 75-81
Genus IF E[R] E[ln (Eu)] E[WPC] E[NIP] E[NUP] E[CI]
Shewanella 7/7 1.0 –14534.8 ± 8196.6 1369.1 1841 1022 1
Cupriavidus 1/7 2.0 –15.5 ± 0.0 3.2 15 1 7
Kyrpidia 1/7 2.0 –7.7 ± 0.0 1.0 1 1 49
Azoarcus 1/7 3.0 –5.6 ± 0.0 1.8 19 0 6
Polaromonas 1/7 3.0 –4.1 ± 0.0 0.7 6 0 12
The numerical entries in the table are the expected values E[X]. The E[ln (Eu)] is followed by its standard deviation ±σX
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analyses, for a dataset composed of 18,000 MS/MS spectra, it
takes MiCId about 15 min to finish the analyses using 4
2.4GHz logical cores in parallel. The computational/analysis
time can be reduced by increasing the number of logical cores
used.
Statistical Method for Microbial Identification
The efficacy of our statistical method relies on two assump-
tions: (1) statistical significances, E-values (P-values), assigned
at the peptide level are accurate; (2) microorganisms used for
database construction are correctly classified into the hierarchy
of strains, species, and genera. The first assumption can be
verified computationally by searching a database made of
decoy/random peptides [55] with a set of MS/MS spectra as
queries. A decoy database was created using the same proce-
dure employed to generate a microbial peptide sequence data-
base except that each downloaded protein sequence had its
sequence reversed. MS/MS spectra of SN1-SN8 were used as
queries to search the decoy database and the expected number
of errors per query below an E-value cutoff was computed and
plotted versus the cutoff E-value. Figure 2 shows that the
computed curves trace very closely the theoretical line, y=x,
indicating that the computed E-values assigned to peptides
identified are indeed accurate. Regarding the second assump-
tion, microorganisms’ taxonomic classification has improved
and is expected to continually improve because of advances in
DNA sequencing technology and a polyphasic approach that
utilizes genotypic, chemotypic, and phenotypic information
during taxonomic classification [67]. However, taxonomic
classification of some microorganisms appears dubious at the
moment and could influence microorganism identification
[50]. For example, some studies suggest that the Shigella
flexneri species should be classified as a strain of Escherichia
coli [68, 69].
To provide statistical significance at the genus, species, and
strain levels, one may compute a unified E-value Eu by com-
bining the spectrum-specific E-values of the CIPs belonging to
the same genus, species, and strain, respectively. The
spectrum-specific E-value assigned to a peptide is given by
Table 4. Bacterial Identification at the Species Level for the PNNL Dataset
Escherichia coli K-12 sample number 29-39
Species IF E[R] E[ln (Eu)] E[WPC] E[NIP] E[NUP] E[CI]
E. coli 11/11 1.0 –6473.8 ± 341.9 595.4 1582 14 1
H. halophila 2/11 2.0 –14.0 ± 3.3 1.7 12 1 2
C.P. marinum 1/11 2.0 –6.2 ± 0.0 1.0 3 1 50
E. hirae 1/11 3.0 –5.7 ± 0.0 1.0 2 1 27
Ruminococcus 1/11 3.0 –3.7 ± 0.0 1.0 2 1 31
Mycobacterium tuberculosis H37Rv sample number 40-48
Species IF E[R] E[ln (Eu)] E[WPC] E[NIP] E[NUP] E[CI]
M. tuberculosis 9/9 1.0 –3697.0 ± 394.8 391.5 887 5 1
E. harbinense 1/9 2.0 –5.7 ± 0.0 1.0 1 1 93
M. petrolearius 1/9 2.0 –3.7 ± 0.0 1.0 1 0 550
P. oguniense 1/9 2.0 –3.6 ± 0.0 1.5 2 0 779
S. smaragdinae 1/9 3.0 –2.7 ± 0.0 1.0 1 0 47
Salmonella typhimurium ATCC 14028 sample number 49-56
Species IF E[R] E[ln (Eu)] E[WPC] E[NIP] E[NUP] E[CI]
S. enterica 8/8 1.0 –5099.6 ± 604.7 498.5 1043 133 1
H. halophila 1/8 2.0 –14.3 ± 0.0 2.0 6 1 4
P. limnophilus 1/8 2.0 –6.9 ± 0.0 1.0 2 1 24
D. salexigens 1/8 2.0 –5.7 ± 0.0 1.2 3 1 13
C.M. haemolamae 1/8 3.0 –5.6 ± 0.0 1.0 1 0 220
Yersinia pestis CO92 sample number 57-65
Species IF E[R] E[ln (Eu)] E[WPC] E[NIP] E[NUP] E[CI]
Y. pestis 9/9 1.0 –5888.8 ± 566.1 549.4 1317 24 1
N. PP1Y 1/9 4.0 –7.0 ± 0.0 1.5 7 0 4
C.C. ruddii 1/9 2.0 –4.5 ± 0.0 1.0 1 1 3
T. forsythia 1/9 3.0 –3.8 ± 0.0 1.0 3 0 11
Ruminococcus 1/9 3.0 –3.7 ± 0.0 1.0 2 0 43
Yersinia pseudotuberculosis PB1 Plus sample number 66-73
Species IF E[R] E[ln (Eu)] E[WPC] E[NIP] E[NUP] E[CI]
Y. pseudotuberculosis 9/9 1.0 –5198.7 ± 516.8 490.1 1173 23 1
N. aromaticivorans 1/9 2.0 –15.9 ± 0.0 2.5 6 2 4
S. aciditrophicus 4/9 4.2 –0.3 ± 4.5 0.8 5 0 4
C. U. diaspidicola 4/9 2.2 0.6 ± 0.9 0.2 2 0 116
M. ruber 1/9 2.0 0.8 ± 0.0 0.5 3 0 21
Shewanella oneidensis MR-1 sample number 74-81
Species IF E[R] E[ln (Eu)] E[WPC] E[NIP] E[NUP] E[CI]
S. oneidensis 7/7 1.0 –10280.9 ± 5954.4 949.7 1660 402 1
K. tusciae 1/7 2.0 –7.6 ± 0.0 1.0 1 1 35
A. BH72 1/7 2.0 –5.2 ± 0.0 1.7 11 0 7
P. NH8B 1/7 5.0 –3.8 ± 0.0 1.8 11 0 6
M. versatilis 1/7 2.0 –3.7 ± 0.0 1.0 3 1 20
The numerical entries in the table are the expected values E[X]. The E[ln (Eu)] is followed by its standard deviation ±σX
G. Alves et al.: Identification of Microorganisms 201
multiplying the database size nmw (Bonferroni’s correction
factor) by that peptide’s spectrum-specific P-value (P), i.e.,
E ¼ nmw  P; ð1Þ
where nmw is the total number of qualified peptides in the
database (i.e., peptides that are within the allowed precursor
ion MWET).
We compute Eu, the unified E-value, by executing the
following steps. First, we obtain a corresponding set of CIPs
identified with an appropriate E-value cutoff; second, based
on the CIP coverage, we cluster at either genus, species, or
strain level; third, appropriate weights are then assigned to
each CIP; finally, the unified P-value is computed, yielding
the unified E-value upon multiplication of the correct
Bonferroni factor.
The first step is important. For a given LCMS experi-
ment, thousands of MS/MS spectra are analyzed and by
random chance some identified peptides will have
statistically significant E-values (SSEs). Identified peptides
with SSEs that occur by chance are spurious and are called
FP. In this study, for each sample analyzed, only peptides




where ns is the total number of MS/MS spectra of the
sample, are used to compute the Eu.
When a peptide is identified in multiple spectral searches
with E-value less than Ec, the smallest E-value of the iden-
tified peptide is kept and the rest of the E-values are ig-
nored. We choose the most conservative approach by keep-
ing only the smallest E-value and we have not explored the
possibility of combining E-values corresponding to the
same peptide.
We then transform the E-values of CIPs into the database P-
values. This is accomplished by assuming that the occurrence
of peptides with SSEs (i.e., peptides with small E-values) in a
Table 5. Bacterial Identification at the Strain Level for the PNNL Dataseta
Strain IF E[R] E[ln (Eu)] E[WPC] E[NIP] E[NUP] E[CI]
E.c. K-12 MG1655 11/11 1.1 –6363.9 ± 333.9 583.0 1566 0 1
E.c. K-12 W3110 11/11 2.0 –6353.7 ± 331.3 582.0 1564 0 1
E.c. BW2952 11/11 2.9 –6339.0 ± 332.1 580.9 1561 0 1
H.h. SL1 2/11 4.0 –13.9 ± 3.4 1.7 12 1 2
C.P. m.IMCC1322 1/11 4.0 –6.1 ± 0.0 1.0 3 1 66
Mycobacterium tuberculosis H37Rv sample number 40-48
Strain IF E[R] E[ln (Eu)] E[WPC] E[NIP] E[NUP] E[CI]
M.t. H37Rv 9/9 1.3 –3656.0 ± 386.2 387.3 884 0 1
M.t. H37Ra 9/9 1.7 –3652.6 ± 386.4 386.9 883 0 1
M.t. F11 9/9 3.9 –3640.2 ± 384.6 385.9 881 0 1
M.t. KZN4207 9/9 4.2 –3639.3 ± 383.3 385.8 880 0 1
M.t. CTRI2 9/9 4.6 –3637.0 ± 381.9 385.5 880 0 1
Salmonella typhimurium ATCC 14028 sample number 49-56
Strain IF E[R] E[ln (Eu)] E[WPC] E[NIP] E[NUP] E[CI]
S.T. 14028S 8/8 1.9 –4093.9 ± 498.5 403.9 1027 0 1
S.T. UK1 8/8 2.5 –4089.1 ± 493.6 403.3 1025 0 1
S.T. T000240 8/8 3.0 –4087.1 ± 495.2 403.0 1025 0 1
S.T. U288 8/8 4.1 –4083.3 ± 497.5 402.5 1024 0 1
S.T. ST4-74 8/8 4.1 –4080.9 ± 494.9 402.6 1023 0 1
Yersinia pestis CO92 sample number 57-65
Strain IF E[R] E[ln (Eu)] E[WPC] E[NIP] E[NUP] E[CI]
Y.p. CO92 9/9 1.0 –5699.2 ± 545.9 531.8 1317 0 1
Y.p. M. 91001 6/9 2.2 –5452.2 ± 346.2 512.0 1266 0 1
Y.p. KIM10 3/9 3.3 –5272.1 ± 273.3 497.7 1231 0 1
Y.p. P. F 1/9 2.0 –5071.8 ± 0.0 486.0 1212 0 1
N. PP1Y 1/9 4.0 –6.9 ± 0.0 1.5 7 0 4
Yersinia pseudotuberculosis PB1 Plus sample number 66-74
Strain IF E[R] E[ln (Eu)] E[WPC] E[NIP] E[NUP] E[CI]
Y.p. PB1 9/9 1.0 –5048.1 ± 502.3 475.7 1172 3 1
Y.p. IP32953 7/9 2.0 –4868.1 ± 499.6 463.8 1145 0 1
N.a. DSM12444 1/9 3.0 –15.7 ± 0.0 2.5 6 2 4
S.a. SB 4/9 7.8 –0.1 ± 4.5 0.8 5 0 4
C.U. d. ASNER 4/9 2.8 0.7 ± 1.0 0.2 2 0 184
Shewanella oneidensis MR-1 sample number 75-81
Strain IF E[R] E[ln (Eu)] E[WPC] E[NIP] E[NUP] E[CI]
S.o. MR1 7/7 1.0 –10280.4 ± 5954.4 949.5 1660 402 1
K.t. DSM2912 1/7 2.0 –7.6 ± 0.0 1.0 1 1 54
C.m. CH34 1/7 3.0 –6.4 ± 0.0 1.1 8 0 2
A. BH72 1/7 2.0 –4.2 ± 0.0 1.7 11 0 4
M. 301 1/7 2.0 –3.7 ± 0.0 1.0 3 1 13
The numerical entries in the table are the expected values E[X]. The E[ln (Eu)] is followed by its standard deviation ±σX
202 G. Alves et al.: Identification of Microorganisms
database are infrequent events and can be modelled by a
Poisson process [59, 70]. The E-values are then transformed
into the database P-values by
P Eð Þ ¼ 1 − e−E; ð2Þ
where P(E) represents the probability that at least one event
occurs by random chance with E-value less than or equals to E.
The second step is necessary since microorganisms can
have highly homologous proteomes. As a consequence, a large
number of CIPs may be shared among many microorganisms.
To avoid false identification, it is necessary to have a clustering
procedure to group microorganisms that share a significant
number of CIPs.
We employ a peptide-driven clustering procedure
whose algorithm is described below. First, CIPs are
assigned to the different genera of microorganisms pres-
ent in the database. Second, genera are sorted in order of
decreasing number of CIPs. Third, starting from the best
ranked genus, any other lower ranked genus will cluster to
the former if 7/8 or more of the latter’s identified peptides
are also identified by the former. Once the worst ranked
genus is reached, the process will repeat itself until all the
unclustered genera have been used as a starting point, but
not more than once. The first genus entering a cluster is
called the head of that cluster, whereas other genera are
the members of that cluster. Each cluster is assigned a
cluster index (CI), which is shared by the head and the
members of that cluster. There is, however, an exception
to the general clustering rule. When a genus contains five
or more evidence peptides that are not shared with other
genera, it can only be a cluster head. Each cluster head is
then selected as the best representative genus for its
cluster.
The identical clustering procedure is used for identifications
at species and strain levels. Our clustering procedure assumes
that in the database the correct microorganisms are present and
their proteomes should explain the majority of the CIPs. If the
correct microorganisms are not in the database, the closely
related ones should explain the majority of CIPs. Therefore,
MiCId provides microbial identifications if we know a priori
that the underlying microorganism is in the database; on the
other hand, if we know a priori that the underlying microor-
ganism is not in the database, MiCId can be used for microbial
classifications.
The third step is to weight the database P-value of an
identified peptide π according to the number of genus clusters
(Cπ,g), species clusters (Cπ,s), or strain clusters (Cπ,ss) that
contain π in their proteomes. Specifically, when conducting
identification at the genus, species, or strain level, π’s database
P-value is adjusted by raising it to the power ofwπ, wherewπ is
define as 1/(Cπ,g!), 1/(Cπ,s!), or 1/(Cπ,ss!), respectively. Note
that 1/C! is the simplex volume bounded by x1≤i≤C≥0 and
∑Ci¼1xi≤1. This procedure is applied to all peptides identified
with E-value less than 1, not just to CIPs. Apparently, incorrect
taxonomic classification or missing polymorphism information
might reduce the value of Cπ,g, Cπ,s,and Cπ,ss used to adjust π’s
database P-value, yielding a stronger weight than warranted.
To prevent a CIP from having excessive weight, we shall use
the value 1/2 for both C=1 and C=2.
Finally, to obtain an unified P-value (Pu) , let




be the set of adjusted
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procedure, with ng→ns (or nss), can be used at species and
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where M ¼ ∑Ngj¼1wj E≤1ð Þ
l m
with Ng being the total number
of identified peptides (with E-value ≤ 1) mappable to genus g,
and θ(x) takes value 1 when x>0 and 0 otherwise. The first term
of the right hand side of Equation 6 contains the conditional
probability (4) and a binomial factor that gives the probability
of getting m peptides (each with P-value less than Pc) out ofM
peptides. Consider sample M independently uniformly distrib-
uted random numbers in the range[0, 1]).
The product of the two aforementioned contributions,
namely, the binomial factor and the truncatedP-value (4), gives
the joint probability for obtainingm random numbers, each less
than Pc, whose product is less than τ. Each additional term in
Equation 6 carries a similar meaning: it represents the joint
probability, when samplingM random numbers, for obtaining j
random numbers, each less thanPc, whose product is less than
τ. The unified P-value is computed for an example in the
electronic supplementary material.
The unified E-value Eu is then obtained by
Eu ¼ Pu  B E≤Ecð Þ; ð7Þ
where the Bonferroni correction factor B(E≤Ec) denotes the
number of genus clusters, species clusters, or strain clusters that
contain at least one evidence peptide with E-value less than the
cutoff Ec=1/ns.
Results
We have mentioned, in the Introduction, that using a spectrum-
specific significance measure (such as E-value) enables
comparison/unification of statistical significances. Evidently,
the unified significancemeasure can be accurate only if the per-
spectrum significance assignments are accurate and the method
to combine them is rigorous. There is no doubt that the accu-
racy of the unified E-value critically affects the performance of
our application.
To evaluate the accuracy of the computed Eu, we used
spectra from SN1–SN81 to query a decoy bacterial peptide
database, whose construction was described earlier. Panels a, b,
and c of Figure 3 display the curves of the expected Eu (E[Eu])
versus rank for microbial identifications at the genus, species,
and strain levels respectively. E[Eu] at a given rank was com-
puted by averaging over all the Eu s of identified microorgan-
isms having that rank from results of SN1 through SN81.
Identified microorganisms are ranked by Eu in ascending order,
meaning the best ranked microorganism has the smallest Eu. If
the computed Eus are accurate, plotting E[Eu] versus its corre-
sponding rank should yield a curve close to the y=x line. As
shown in Figure 3, these curves are bounded by the two dotted
lines, y=3x and y=x/3, indicating that on average the computed
Eus are no more than a factor of three off. Further, these curves
seem always to lie below the y=x line, suggesting that the
computed Eus are conservative.
The PNNL and the in-house datasets were used to evaluate
MiCId’s microbial identification. Within either dataset, we
average the analysis results from samples containing the same
underlying organism. A microorganism o (not necessarily the
underlying organism of the samples) may be reported in anal-
yses of A out of B samples. In this case, the microorganism o is
said to have identification fraction (IF) equal to A/B. For
microorganism o, the expected values (averaged only over
the A samples that report o) of rank (R), natural log of Eu,
weighted peptide count (WPC), the number of identified pep-
tides (NIP), the number of unique peptides (NUP), and cluster
index (CI) are computed and denoted, respectively, by E[R],
E[ln Eu], E[WPC], E[NIP], E[NUP], and E[CI]. To be more
precise, for each sample analyzed, R is the rank of o in the
identified microorganisms when sorted in increasing order of
assigned Eu, computed via Equation 7; WPC is defined as the
sum of weights (wi) of identified peptidesmappable to o; NIP is
the number of identified peptides belonging to o; NUP is the
number of identified peptides belonging exclusively to o; CI is
the index for the cluster o belongs to.
Microbial Identification for PNNL Dataset
To evaluate the effectiveness of MiCId in terms of microbial
identification at the genus, species, and strain levels, we run
MiCId using spectra from SN29 through SN81 (the whole
PNNL dataset). Bacterial identification at genus level for the
PNNL dataset is displayed in Table 3, within which one sees
that for each sample the correct genus is identified and ranked
number one (E[R] = 1). Table 3 also shows that the correct
genera identified have E[NUP] greater than zero and also
greater than the E[NUP] of the lower-ranked genera.
Table 4 shows that the correct species are identified with
rank one for all the PNNL’s samples. It also shows that the
correct species’s E[NUP] remains positive but smaller than the
corresponding genus’s E[NUP]. This is expected because the
proteome (or peptidome) similarity among species within the
same genus tends to be stronger than that among genera.
Table 4 also shows that the clustering procedure manages to
cluster identified species that are statistically significant and
sharing identical peptides, thus preventing false identifications.
In Table 4, in terms of E[NIP] and E[WPC], we also noted a
clear separation between the best ranked species and the lower-
ranked species.
Table 5 shows the results for microbial identification at the
strain level. Consistently correct identification across all sam-
ples at the strain level was obtained only for three strains:
Yersinia pestis CO92, Yersinia pseudotuberculosis PB1, and
Shewanella oneidensis MR-1. The other three strains,
Escherichia coli K-12, Mycobacterium tuberculosis H37Rv,
and Salmonella typhimurium ATCC 14028were identified with
expected ranks better than two. The total number of strains
present in the database varies by species: 58 Escherichia coli
strains, 29 Salmonella typhimurium strains, 19Mycobacterium
tuberculosis strains, 12 Yersinia pestis strains, 4 Yersinia pseu-
dotuberculosis strains, and 1 Shewanella oneidensis strain. The
large number of strains within each of the first three species
might partially explain why it was difficult to have the correct
204 G. Alves et al.: Identification of Microorganisms
strains rank number one across all samples. An in-depth dis-
cussion of this difficulty based on peptidome similarities
among strains is given in the Discussion section. Although
the correct strains were not always identified as the best ranked
ones, they were, however, always identified within the best
ranking strain cluster. That is, for the correct strains E[CI] =1
even when E[R]>1.
Microbial Identification for the In-House Dataset
The in-house dataset, produced using different sample prepa-
ration methods from the PNNL dataset, were used to examine
the robustness of the analysis pipeline for microorganism iden-
tifications. The main difference between batch one and the
other two batches was how the tryptic digestion of protein
was carried out. In batches two and three, the protein digestion
step of batch one was modified by adding a cleavable surfactant
prior to trypsin digestion, aiming to increase the number of
CIPs. Table 6 displays, for samples collected at different ODs,
the CIP counts as the maximally allowed MCS of candidate
peptides increases from two to five. The number of CIPs in
batch two appears to be higher than that in batch one. However,
due to the limited number of data points and the fact that the
samples were acquired at different OD values, the robustness of
this trend should be verified by a larger study with more data
points collected at same OD values.
Figure 4 displays the precursor ions’ molecular weight and
charge distributions. The green curves in panels a and b are for
SN31 (from the PNNL dataset), and they show that out of the
15,988 MS/MS spectra of SN31, approximately 85% have
precursor ion molecular weights less than 3000 Da, and that
the average precursor ion charge state is about 3. Similar results
are also obtained for the other samples within the PNNL dataset
(data not shown). For the in-house dataset, the curves for SN1
(blue) and SN9 (red) show, respectively, that about 55% and
37% of precursor ions have molecular weights less than 3000
Da, a considerable difference from the 85% obtained for the
PNNL dataset. This difference is probably due to the different
procedures used for sample preparation. Comparing the curves
of panel d with those of panel f, one finds that the average
precursor ion charge is around 3 for SN1-4, whereas for SN9-
12 it is around 5. Panels a, c, and e of Figure 4 show that the
tryptic peptides produced by the in-house procedures tend to be
longer than those in the PNNL samples. Given that precursor
ion charge determination for longer peptides can be inaccurate,
this may partly explain the lower number of CIPs obtained
from these samples than from the PNNL samples.
Tables 7 and 8 summarize the results obtained for microbial
identifications at the genus and species levels for the in-house
dataset. Individual analysis for each batch can be found in the
Supplementary Tables S3-S8. Tables 7 and 8 show that
E[NUP]s for Pseudomonas aeruginosa and Salmonella
enterica samples remain relatively large given that the number
of CIPs from the in-house dataset are much smaller than that
from the PNNL dataset. As for the Escherichia coli samples, a
low E[NUP] was observed and the correct genus was not
always identified as the top ranking one. This can be due to
several reasons. First, it is known that the Escherichia coli
proteome contains a trypsin inhibitor [72], undermining the
digestion efficiency of trypsin, producing less complete diges-
tions, and consequently yielding a low number of CIPs.
Second, the closeness between Shigella and Escherichia [68,
69] robs E[NUP] out of Escherichia, lowering the identifica-
tion confidence of Escherichia. The third cause is common to
all the in-house samples: our lysis procedure via formic acid
might not be as efficient in breaking the cell walls as using
mechanical disruptions [58, 73].
Discussion
Evidently, the clustering procedure employed requires a suitable
cutoff ρc for making the decision whether or not a genus/species/
strain should be clustered with the head genus/species/strain of a
cluster. If ρc is too small, large clusters are likely to form,making
difficult the identification of multiple microorganisms. That is,
too small a ρc can introduce false negatives. At the other ex-
treme, a large ρc can lead to significant identifications of multi-
ple microorganisms even when the sample is made of only one
microorganism. That is, too large a ρc can introduce false pos-
itives. It appears that using 7/8 for ρc is a reasonable choice,
producing no false positives. Although, the dataset used did not
contain any samples of multiple microorganisms, the method
proposed might be able to handle such cases albeit a separate
independent study must be conducted for verification.
A positive E[NUP] provides important supporting evi-
dence for the identified microorganisms, but it should not be
Table 6. The Number of CIPs at the 1% False Discovery Rate for the In-House
Dataset
Sample from batch one Samples from batch two
Escherichia coli Escherichia coli
SN 1 2 3 4 9 10 11 12
OD 0.30 0.75 1.07 1.34 0.34 0.66 1.01 1.34
NMCS Number of CIPs Number of CIPs
2 67 129 15 47 480 197 214 486
3 101 186 23 72 731 303 322 725
4 132 227 30 95 941 385 415 906
5 155 264 39 116 1077 456 484 1036
Pseudomonas aeruginosa Pseudomonas aeruginosa
SN 5 6 7 8 13 14 15 16
OD 0.38 0.65 0.90 1.50 0.43 0.64 1.12 1.50
NMCS Number of CIPs Number of CIPs
2 115 147 70 147 187 175 166 177
3 196 383 129 244 320 294 281 296
4 266 514 180 317 420 377 372 389
5 311 610 228 376 491 448 436 456
Salmonella enterica
SN 17 18 19 20
DO 0.42 0.68 0.96 1.34
NMCS Number of CIPs Number of CIPs
2 186 186 156 179
3 283 284 233 263
4 367 365 291 334
5 427 429 337 378
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used as the sole evidence. As more protein sequences and
genomic sequences become available in biological data-
bases, the E[NUP] value is expected to decrease for most
microorganisms. Our study indicates that Eu is a more
robust measure than E[NUP]. For example, in Table 4, for
the Mycobacterium tuberculosis H37Rv samples, the rela-
tive difference between the two top ranked species in terms
of E[NUP] is small compared with that of E[ln Eu]. This
demonstrates an advantage of using E-values. The comput-
ed Eu seems to carry more discriminating power than dif-
ferent quantities based on the number of identified peptides.
For this reason, our method uses all identified peptides with
E-value less than Ec to compute Eu.
One difficulty in correctly identifying a microorganism
arises from the fact that different microorganisms may have
similar proteomes/genomes. This complication intensifies if
one tries to separate microbes of highly similar proteomes/
genomes, a likely scenario as more proteomes/genomes of
newly discovered microorganisms become available. For ex-
ample, our peptidome approach has no difficulty in identifying
the correct Escherichia genus while analyzing the PNNL
dataset because the inter-genus peptidome similarity is gener-
ally weak (see Supplementary Figure S1). However, the sub-
stantial similarities among different (sub)strains of Escherichia
Coli (see Supplementary Figure S2) hinder us from consistent-
ly identifying correct strains. One way to alleviate this problem
is to utilize additional information to reduce the number of
candidate microorganisms in a database. For example, under
the assumption that the correct microorganism is in the data-
base, and given that it is pathogenic, we can then bypass all the
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Figure 4. Molecular weight and charge distribution. The curves in panels (a)–(f) display the molecular weight and charge
distributions obtained for the in-house dataset under protocols one and two. Also displayed in panels (a) and (b) are the molecular
weight and charge distributions for SN 31 from the PNNL dataset. Similar molecular weight and charge distributions like the one
observed for SN 31 are obtained for the other samples from the PNNL dataset
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non-pathogenic microorganisms during identifications.
Another scheme that could potentially improve microbial iden-
tifications is to combine the results obtained from microbial
identification using a MALDI-based or PCR-ESI-MS-based
system with the analysis results from an LCMS experiment.
Table 6 shows that for the in-house dataset there is a notable
difference in the number of CIPs when allowing up to two
MCS versus up to five MCS. This observation is consistent
across all samples. This indicates that tryptic digestion of
proteins can be improved. Based on recent studies [74, 75],
we believe that increasing the digestion time from 15 to 60 min
at 50°C can be our next immediate improvement. In addition to
increasing the number of CIPs, better tryptic digestion reduces
the occurrences of missed cleavages, allowing the analyses to
be done with a smaller allowed MCS. This leads to a reduction
in number of candidate peptides during database search, which
not only improves peptide identification sensitivity but also
speeds up the data analyses. Furthermore, shorter tryptic pep-
tides hold fewer protons. This leads to peptides with lower
charge states, which not only allows for more accurate charge
determinations of the precursor ions but also produces less
convoluted m/z fragments that are better captured by the scor-
ing functions implemented in current database search tools.
The data displayed in Figure 4 indicates that the MS/MS
spectra acquired for the PNNL dataset represent the fragmen-
tation spectra of short peptides containing low charges, making
peptide identification an easier task for currently available
database search tools [54, 62, 63]. The MS/MS spectra for
the in-house dataset, however, represent the fragmentation
spectra of longer and higher charge-containing peptides, mak-
ing peptide identification challenging. Panel b of Figure 4
shows that SN1 has a larger number of precursor ions at low
Table 7. Bacterial Identification at the Genus Level for the In-House Dataseta
Escherichia coli sample number 1-4, 9-12, and 21-26
Genus IF E[R] E[ln (Eu)] E[WPC] E[NIP] E[NUP] E[CI]
Escherichia 14/14 1.4 –365.2 ± 290.4 42.1 115 1 1
Shigella 14/14 1.6 –349.6 ± 271.8 40.1 114 0 1
Enterobacter 2/14 5.0 –36.8 ± 24.4 5.1 18 0 1
Enterobacteriaceae 1/14 3.0 –13.9 ± 0.0 1.8 8 0 1
Citrobacter 1/14 4.0 –13.2 ± 0.0 1.5 6 0 1
Pseudomonas aeruginosa sample number 5-8, 13-16 and 27-28
Genus IF E[R] E[ln (Eu)] E[WPC] E[NIP] E[NUP] E[CI]
Pseudomonas 10/10 1.0 –598.7 ± 647.8 71.3 102 34 1
Acidovorax 1/10 2.0 –23.0 ± 0.0 2.0 4 2 3
Azospira 5/10 4.2 –5.6 ± 8.3 1.2 2 0 3
Thiobacillus 1/10 2.0 –5.6 ± 0.0 1.0 2 1 5
Rothia 1/10 3.0 –4.8 ± 0.0 1.0 1 0 7
Salmonella enterica sample number 17-20
Genus IF E[R] E[ln (Eu)] E[WPC] E[NIP] E[NUP] E[CI]
Salmonella 4/4 1.0 –232.1 ± 21.1 27.1 61 7 1
Haloferax 2/4 2.5 –7.2 ± 0.5 1.0 1 1 10
Pseudovibrio 1/4 2.0 –5.5 ± 0.0 1.0 1 0 11
Cupriavidus 4/4 2.8 –5.3 ± 2.5 1.1 2 1 6
Aliivibrio 3/4 4.0 –1.7 ± 2.3 0.8 2 0 4
a The numerical entries in the table are the expected values E[X]. The E[ln (Eu)] it is followed by its standard deviation ±σX
Table 8. Bacterial Identification at the Species Level for the In-House Dataset
Escherichia coli sample number 1-4, 9-12, and 21-26
Species IF E[R] E[ln (Eu)] E[WPC] E[NIP] E[NUP] E[CI]
E. coli 14/14 1.4 –364.2 ± 288.0 41.9 115 1 1
S. boydii 10/14 2.1 –188.3 ± 80.8 22.8 65 0 1
S. flexneri 10/14 4.1 –178.0 ± 76.3 22.1 63 0 1
S. dysenteriae 9/14 3.4 –168.0 ± 73.6 20.4 57 0 1
S. sonnei 8/14 4.2 –154.9 ± 69.2 19.1 54 0 1
Pseudomonas aeruginosa sample number 5-8, 13-16, and 27-28
Species IF E[R] E[ln (Eu)] E[WPC] E[NIP] E[NUP] E[CI]
P. aeruginosa 10/10 1.0 –526.3 ± 557.5 59.9 94 23 1
A. KKS102 1/10 2.0 –26.0 ± 0.0 2.0 4 2 4
P. stutzeri 1/10 2.0 –16.1 ± 0.0 1.8 7 0 2
E. 638 tid399742 1/10 3.0 –7.5 ± 0.0 1.2 5 0 2
E. asburiae 1/10 5.0 –7.1 ± 0.0 1.2 6 0 2
Salmonella enterica sample number 17-20
Species IF E[R] E[ln (Eu)] E[WPC] E[NIP] E[NUP] E[CI]
S. enterica 4/4 1.0 –206.7 ± 15.2 24.7 61 4 1
S. bongori 1/4 2.0 –157.3 ± 0.0 19.6 56 0 1
H. mediterranei 2/4 3.0 –7.6 ± 0.8 1.0 1 1 11
C. metallidurans 4/4 2.5 –6.7 ± 2.9 1.1 2 1 8
P. FO BEG1 1/4 4.0 –5.5 ± 0.0 1.0 1 0 10
a The numerical entries in the table are the expected values E[X]. The E[ln (Eu)] is followed by its standard deviation ±σX
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charge states than SN9. However, because SN1 contains fewer
precursor ions, with molecular weight <6000 Da than SN9,
SN1 ends up having a smaller number of CIPs than SN 9 (see
Table 6).
It is worthwhile to further discuss what may cause the
number of identified peptides from the in-house dataset to be
much smaller than that from the PNNL dataset. In addition to
the reasons described, we believe that the sample preparation
prior to the tryptic digestion as well as additional
chromatography/fractionation also contribute. For each
PNNL sample, a modified bead beating method was applied
to break the cell walls. This customized cell-wall breaking
protocol, described earlier, increases the exposure depth of
microbial proteome for digestion and thus enables better pro-
teome coverage. In addition, compared with the in-house pro-
cedure, we note another difference from the PNNL workflow:
many samples were each prefractionated to 24 fractions by
strong cation exchange (SCX) chromatography prior to
LCMS analysis. This additional chromatography step facili-
tates better peptide separation and thus promotes a large num-
ber of identifications. Evidently, depending on the goal, the
optimal protocol varies. In terms of classifications, it is best to
optimize the proteome coverage. However, in terms of clinical
applications, one may in addition like to minimize the amount
of time required for confident identifications.
Conclusion
In this study, we have proposed a pipeline for microbial
identification/classification by processing MS/MS data ac-
quired in a high resolution mass spectrometer. Using a large
number of samples from the PNNL dataset, we have shown
that the proposed pipeline is able to confidently identify micro-
organisms at the genus and species levels when the sample
preparation was optimized. The importance of an optimized
sample preparation is also reflected from the analyses of our in-
house Escherichia samples, where the correct Escherichia
genera are often accompanied by Shigella because of weak
separation in the numbers of observable evidence peptides.
These results illustrate that the proposed pipeline can be a
useful tool for microorganism identifications if sample prepa-
ration is optimized. It should be noted that this pipeline pro-
vides accurate E-values at the microbial level (Eus). Having
accurate statistical significance is advantageous as it provides
the correct confidence assignments to the microorganisms
identified.
Our results also indicate that microbial identification at the
strain level is a challenging task, as the correct strain may not
always attain the best rank. This problem will only become
harder as the genomes of new microorganisms are sequenced
and made available in public databases. To meet the challenge
of increasing number of sequenced genomes will require inno-
vations and technological advances in the areas of chromatog-
raphy, mass spectrometry, statistical analyses, and algorithm
developments. That is, a concerted effort of the community is
needed.
While we have focused on microbial identifications using
samples each composed of one microorganism, in the next
phase, we will evaluate how the proposed pipeline performs
when using samples containing multiple microorganisms. Our
(automated) pipeline for microbial identifications has been
implemented in a software tool called MiCId, a command line
C++ program. MiCId can be downloaded freely at http://www.
ncbi.nlm.nih.gov/CBBresearch/Yu/downloads.html.
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